Literature DB >> 11342978

Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate.

S H Selman1, D Albrecht, R W Keck, P Brennan, S Kondo.   

Abstract

PURPOSE: Previous studies have demonstrated the technical feasibility of destroying prostate tissue using photodynamic therapy for benign and malignant disease. A series of canine studies was performed to evaluate the systemic uptake and distribution of the photosensitizer tin ethyl etiopurpurin (SnET2) in the prostate and surrounding tissues, and determine the optimal combination of drug dose, light dose and time interval between drug and light administration using transurethral and transperineal interstitial light delivery.
MATERIALS AND METHODS: Adult male mongrel source dogs received intravenous bolus injections of 0.5 or 1.0 mg./kg. SnET2 in 4 studies. In the first study the concentration of SnET2 in the prostate and surrounding tissue was measured at various time points after dosing. In the second study a tissue dose response relationship of SnET2-PDT was studied after transperineal interstitial light application. The third and fourth studies evaluated the tissue effects of combined transurethral and transperineal interstitial light application on SnET2 sensitized prostates.
RESULTS: Substantial amounts of SnET2 were measured in the prostate between 24 and 168 hours after infusion. Drug and light dose dependent prostatic tissue necrosis and volume reduction were documented in the dose response relationship study. The combination of transurethral and transperineal light resulted in the extensive destruction of glandular epithelium with minimal damage to surrounding structures. Average prostate volume decreased 52%. Transperineal interstitial light delivery with multiple diffusers resulted in substantial glandular destruction of the prostate. An average volume reduction of more than 60% was achieved.
CONCLUSIONS: SnET2-PDT is a viable minimally invasive treatment modality for prostate tissue destruction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342978

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  9 in total

1.  Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated photodynamic therapy on canine prostate pretreated with ionizing radiation.

Authors:  Zheng Huang; Qun Chen; Nadira Trncic; Susan M LaRue; Pierre-Hervé Brun; Brian C Wilson; Howard Shapiro; Fred W Hetzel
Journal:  Radiat Res       Date:  2004-06       Impact factor: 2.841

Review 2.  Photodynamic therapy for focal ablation of the prostate.

Authors:  Nimalan Arumainayagam; C M Moore; Hashim U Ahmed; M Emberton
Journal:  World J Urol       Date:  2010-05-09       Impact factor: 4.226

3.  Effects of photodynamic therapy on peripheral nerve: in situ compound-action potentials study in a canine model.

Authors:  Kenneth C Dole; Qun Chen; Fred W Hetzel; Lawrence R Whalen; Dominique Blanc; Zhen Huang
Journal:  Photomed Laser Surg       Date:  2005-04       Impact factor: 2.796

4.  The effect of Tookad-mediated photodynamic ablation of the prostate gland on adjacent tissues--in vivo study in a canine model.

Authors:  Zheng Huang; Qun Chen; Kenneth C Dole; Al B Barqawi; Yang K Chen; Dominique Blanc; Brian C Wilson; Fred W Hetzel
Journal:  Photochem Photobiol Sci       Date:  2007-08-22       Impact factor: 3.982

5.  Treatment planning using tailored and standard cylindrical light diffusers for photodynamic therapy of the prostate.

Authors:  Augusto Rendon; J Christopher Beck; Lothar Lilge
Journal:  Phys Med Biol       Date:  2008-02-05       Impact factor: 3.609

6.  Prostate PDT dosimetry.

Authors:  Timothy C Zhu; Jarod C Finlay
Journal:  Photodiagnosis Photodyn Ther       Date:  2006-10-19       Impact factor: 3.631

7.  Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer.

Authors:  Zheng Huang; Qun Chen; David Luck; Jill Beckers; Brian C Wilson; Nadira Trncic; Susan M Larue; Dominique Blanc; Fred W Hetzel
Journal:  Lasers Surg Med       Date:  2005-06       Impact factor: 4.025

Review 8.  Photodynamic therapy: a new approach to prostate cancer.

Authors:  Rolf Muschter
Journal:  Curr Urol Rep       Date:  2003-06       Impact factor: 2.862

Review 9.  Photosensitizers in prostate cancer therapy.

Authors:  Taher Gheewala; Troy Skwor; Gnanasekar Munirathinam
Journal:  Oncotarget       Date:  2017-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.